Given that CD5L− mice had impaired control of bacterial spreading and decreased survival than WT mice in the mid-grade CLP model, we explored whether administration of the recombinant mouse CD5L (rCD5L) protein could synergize with endogenous CD5L levels to combat the overt infection and inflammation likely to develop following a high-grade CLP procedure. The gene discussed is CD5L; the disease is infection.